Published in J Gastrointest Surg on June 01, 2006
The effect of age on short-term outcomes after pancreatic resection: a population-based study. Ann Surg (2008) 1.46
Advanced age is a risk factor for post-operative complications and mortality after a pancreaticoduodenectomy: a meta-analysis and systematic review. HPB (Oxford) (2012) 1.15
Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy. J Am Coll Surg (2011) 1.12
What is the effect of age on pancreatic resection? Adv Surg (2009) 1.06
Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer. Pancreas (2009) 1.00
Results of pancreatic surgery in the elderly: is age a barrier? HPB (Oxford) (2012) 0.93
Outcomes of robot-assisted pancreaticoduodenectomy in patients older than 70 years: a comparative study. World J Surg (2010) 0.92
Resection benefits older adults with locoregional pancreatic cancer despite greater short-term morbidity and mortality. J Am Geriatr Soc (2011) 0.89
Pancreatic resection in elderly patients: should it be denied? Langenbecks Arch Surg (2014) 0.88
The safety of a pancreaticoduodenectomy in patients older than 80 years: risk vs. benefits. HPB (Oxford) (2012) 0.88
Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice? World J Surg Oncol (2013) 0.88
Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis. Pancreas (2013) 0.87
Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients. Radiat Oncol (2013) 0.84
The impact of surgical outcome after pancreaticoduodenectomy in elderly patients. World J Surg Oncol (2011) 0.83
Gastroduodenal artery-preserving pancreaticoduodenectomy after subtotal esophagectomy and gastric pull-up. Langenbecks Arch Surg (2011) 0.80
Implementing an enhanced recovery program after pancreaticoduodenectomy in elderly patients: is it feasible? World J Surg (2015) 0.78
Clinical outcomes of pancreaticoduodenectomy in octogenarians: a surgeon's experience from 2007 to 2015. J Gastrointest Oncol (2016) 0.75
Pancreaticoduodenectomy of pancreatic ductal adenocarcinoma in the elderly. Yonsei Med J (2007) 0.75
Safety of pancreatic resection in the elderly: a retrospective analysis of 556 patients. Ann Gastroenterol (2016) 0.75
Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.96
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol (2013) 2.94
Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg (2006) 2.70
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann Surg (2012) 2.43
Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg (2011) 2.42
Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells (2006) 2.30
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology (2007) 2.25
A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg (2004) 2.20
Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg (2008) 2.10
Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions. Pancreas (2008) 2.05
Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl (2003) 2.01
Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol (2002) 2.00
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet (2006) 1.97
18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. J Nucl Med (2013) 1.61
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry. Ann Surg (2007) 1.51
Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens. Ann Surg (2009) 1.50
Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie. Ann Surg Oncol (2015) 1.46
Inferior vena cava graft-enteric fistula after extended hepatectomy with caval replacement. J Vasc Surg (2011) 1.45
AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group. Cancer (2010) 1.44
Splenic vein-inferior mesenteric vein anastomosis to lessen left-sided portal hypertension after pancreaticoduodenectomy with concomitant vascular resection. Arch Surg (2011) 1.43
Prediction of mortality rate after major hepatectomy in patients without cirrhosis. Arch Surg (2010) 1.42
Histological and immediate postoperative outcome after preoperative cetuximab: case-matched control study. World J Surg (2010) 1.40
Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg (2007) 1.36
One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg (2003) 1.35
Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology (2005) 1.27
Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. Cancer Res (2002) 1.26
Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl (2003) 1.24
Pancreaticogastrostomy decreased relaparotomy caused by pancreatic fistula after pancreaticoduodenectomy compared with pancreaticojejunostomy. Arch Surg (2004) 1.21
Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. J Gen Virol (2006) 1.17
Medial pancreatectomy: a multi-institutional retrospective study of 53 patients by the French Pancreas Club. Surgery (2002) 1.17
Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg (2011) 1.14
Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview. Liver Transpl (2004) 1.09
Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association. HPB (Oxford) (2013) 1.08
Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery (2008) 1.07
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination. Hepatology (2012) 1.07
Multivariate analysis of risk factors for pulmonary complications after hepatic resection. Ann Surg (2012) 1.03
Congenital intrahepatic bile duct dilatation is a potentially curable disease: long-term results of a multi-institutional study. Ann Surg (2007) 1.03
Toward zero pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy. Am J Surg (2006) 1.02
Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group. J Gastrointest Surg (2011) 1.02
Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas. J Gastrointest Surg (2007) 1.02
Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study. J Surg Oncol (2011) 0.97
A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas. PLoS One (2013) 0.96
Impact of radiofrequency assisted hepatectomy for reduction of transfusion requirements. Am J Surg (2007) 0.96
Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization. Ann Surg Oncol (2012) 0.96
Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB (Oxford) (2013) 0.95
First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg (2004) 0.95
Pancreaticoduodenectomy after coronary artery bypass grafting with use of an in situ right gastroepiploic artery graft. Eur J Cardiothorac Surg (2013) 0.95
Arterial and vena caval resections combined with pancreaticoduodenectomy in highly selected patients with periampullary malignancies. Hepatogastroenterology (2002) 0.94
The role of "fatty pancreas" and of BMI in the occurrence of pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg (2009) 0.94